Affiliations: Harvard Radiation Oncology Program, Boston, MA (Drs Saraf, Boyd). Massachusetts General Hospital, Boston, MA (Drs Saraf, Boyd, Jimenez) . Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA (Drs Saraf, Boyd, Franco). University of Florida College of Medicine, Jacksonville, FL (Dr De Leo). Mayo Clinic Comprehensive Cancer Center, Phoenix, AZ (Dr Gawu). MD Anderson Cancer Center, Houston, TX (Dr Pinnix) . University of California, San Francisco, CA (Drs Braunstein, Singer).
Dr. Munshi is the director of radiation oncology, Dr. Sarkar is a senior medical physicist, Dr. Bansal is an assistant consultant, Dr. Rastogi is a senior resident, Dr. Ganesh is the chief medical physicist, and Dr. Mohanti is a senior consultant, all at Manipal Hospitals, New Delhi, India. Dr. Vaishya is the director of neurosurgery, Fortis Memorial Research Institute, Gurgaon, Haryana, India. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.
Dr. Sim is a resident physician (PGY-3), Department of Radiation Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL. Acknowledgement: Many thanks to Stephen A. Rosenberg, MD, MS, for editorial support.
Dr. Chaurasia is a PGY5 chief resident, Dr. Brennan is a PGY4 senior resident, Dr. Erickson is the residency program director and an assistant professor, and Dr. Torgeson is the associate residency program director and an assistant professor, all at National Capital Consortium Radiation Oncology Residency and Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, Bethesda, MD, and Radiation Oncology Service, Department of Radiology, Walter Reed National Military Medical Center, Bethesda, MD. Dr. Walker and Dr. Page are assistant professors, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD. Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. The views expressed in this article are those of the authors and do not reflect the official policy of the Uniformed Services University of the Health Sciences, the Department of Defense or US Government.
Dr. Chaurasia is a PGY5 chief resident at National Capital Consortium/National Cancer Institute Radiation Oncology, Bethesda, MD. Dr. Bhatia is a PGY2 resident physician at Johns Hopkins Medicine, Baltimore, MD. Dr. LeCompte is a PGY1 incoming resident physician at Johns Hopkins Medicine, Baltimore, MD. Dr. Taparra is a PGY1 incoming resident at Stanford University, CA. Dr. Franco is a PGY3 resident physician, Harvard Medical School, Cambridge, MA. Dr. Garda is a PGY5 chief resident, Mayo Clinic, Rochester, MN. Dr. Li is a PGY3 resident physician, University of California, San Francisco. Dr. Pereira is a PGY4 resident physician at Queens University, Kingston, ON, Canada.
Barry W. Goy, MD; Department of Radiation Oncology, Kaiser Permanente, Los Angeles, CA
Chris S. Helmstedter, MD; Department of Orthopedic Oncology, Kaiser Permanente, Baldwin Park, CA
Janis F. Yao, MS; Department of Research and Evaluation, Kaiser Permanente, Pasadena, CA
Sajjad P. Syed, MD; Department of Pathology, Kaiser Permanente, Baldwin Park, CA
Loma Linda University Medical Center (Dr. Lee), Vanderbilt University Medical Center (Dr. Gaines), University of Pennsylvania (Dr. MacDuffie), Mayo Clinic Arizona (Dr. Anderson)
